&Partners’s Abbott Laboratories Position
Does &Partners own Abbott Laboratories (ABT)? Yes — 576.1K shares worth $59M (+0.29% of its 13F portfolio) as of Q1 2026, down from 581.7K shares the prior filed quarter.
Position Value
$59M
Q1 2026
Shares
576.1K
% of Portfolio
+0.29%
Quarters Held
21
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 576.1K | $59M | +0.29% |
| Q4 2025 | 581.7K | $73M | +0.38% |
| Q3 2025 | 531.1K | $71M | +0.46% |
| Q2 2025 | 569.9K | $78M | +0.59% |
| Q1 2025 | 421.0K | $55M | +0.58% |
| Q4 2024 | 376.8K | $43M | +0.51% |
| Q3 2024 | 226.5K | $26M | +0.50% |
| Q2 2024 | 107.8K | $11M | +0.49% |
| Q1 2024 | 22.8K | $3M | +0.36% |
| Q4 2023 | 14.1K | $2M | +0.37% |
| Q3 2023 | 5.3K | $509,599 | +0.24% |
| Q2 2023 | 5.3K | $578,798 | +0.26% |
| Q1 2023 | 5.3K | $537,348 | +0.26% |
| Q4 2022 | 5.3K | $585,961 | +0.29% |
| Q3 2022 | 5.4K | $519,000 | +0.30% |
| Q2 2022 | 5.4K | $582,000 | +0.34% |
| Q1 2022 | 4.5K | $532,000 | +0.30% |
| Q4 2021 | 1.9K | $265,000 | +0.16% |
| Q3 2021 | 2.3K | $270,000 | +0.17% |
| Q2 2021 | 2.3K | $265,000 | +0.17% |
| Q1 2021 | 2.2K | $262,000 | +0.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See &Partners’s full portfolio or all institutional holders of ABT.